These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33639312)

  • 1. Clotrimazole-loaded N-(2-hydroxy)-propyl-3-trimethylammonium, O-palmitoyl chitosan nanoparticles for topical treatment of vulvovaginal candidiasis.
    Facchinatto WM; Galante J; Mesquita L; Silva DS; Martins Dos Santos D; Moraes TB; Campana-Filho SP; Colnago LA; Sarmento B; das Neves J
    Acta Biomater; 2021 Apr; 125():312-321. PubMed ID: 33639312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-based sponges containing clotrimazole for the topical management of vulvovaginal candidiasis.
    Martins F; Morgado DL; Sarmento B; de Camargo ER; das Neves J
    Int J Pharm; 2023 Nov; 647():123508. PubMed ID: 37832705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole and propolis co-encapsulated in chitosan nanoparticles for the treatment of vulvovaginal candidiasis in a murine model.
    da Silva JT; Dantas de Sousa PH; Costa AF; de Menezes LB; Alves SF; Pellegrini F; Amaral AC
    Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37947253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbicidal Polymer Nanoparticles Containing Clotrimazole for Treatment of Vulvovaginal Candidiasis.
    Del Rocío Lara-Sánchez M; Ganem-Rondero A; Nava-Arzaluz MG; Becerril-Osnaya AA; Pérez-Carranza LA; Alcalá-Alcalá S; Mendoza-Muñoz N; Piñón-Segundo E
    AAPS PharmSciTech; 2024 Aug; 25(7):197. PubMed ID: 39174702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low intensity ultrasound-mediated drug-loaded nanoparticles intravaginal drug delivery: an effective synergistic therapy scheme for treatment of vulvovaginal candidiasis.
    Yang M; Cao Y; Zhang Z; Guo J; Hu C; Wang Z; Du Y
    J Nanobiotechnology; 2023 Feb; 21(1):53. PubMed ID: 36782198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis.
    Tapia CV; Hermosilla G; Fortes P; Alburquenque C; Bucarey S; Salinas H; Rodas PI; Díaz MC; Magne F
    Mycopathologia; 2017 Apr; 182(3-4):339-347. PubMed ID: 27882525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD
    J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceutical profile of a clotrimazole nanoemulsion: Evaluation on skin and mucosae as anticandidal agent.
    Soriano-Ruiz JL; Calpena-Capmany AC; Cañadas-Enrich C; Febrer NB; Suñer-Carbó J; Souto EB; Clares-Naveros B
    Int J Pharm; 2019 Jan; 554():105-115. PubMed ID: 30395953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
    Ray A; Ray S; George AT; Swaminathan N
    Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
    Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
    Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clotrimazole multiple W/O/W emulsion as anticandidal agent: Characterization and evaluation on skin and mucosae.
    Soriano-Ruiz JL; Suñer-Carbó J; Calpena-Campmany AC; Bozal-de Febrer N; Halbaut-Bellowa L; Boix-Montañés A; Souto EB; Clares-Naveros B
    Colloids Surf B Biointerfaces; 2019 Mar; 175():166-174. PubMed ID: 30530002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and in vivo evaluation of chitosan-gel containing Mitracarpus frigidus methanolic extract for vulvovaginal candidiasis treatment.
    Campos LM; de Oliveira Lemos AS; da Cruz LF; de Freitas Araújo MG; de Mello Botti GCR; Júnior JLR; Rocha VN; Denadai ÂML; da Silva TP; Tavares GD; Scio E; Fabri RL; Pinto PF
    Biomed Pharmacother; 2020 Oct; 130():110609. PubMed ID: 34321177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of thiosemicarbazide free or within chitosan nanoparticles in a murine model of vulvovaginal candidiasis.
    Araújo DE; de Oliveira AA; Cabral MDS; Costa AF; Silva BC; do Carmo Silva L; de Menezes LB; de Almeida Soares CM; Amaral AC; Pereira M
    Braz J Microbiol; 2020 Dec; 51(4):1465-1473. PubMed ID: 32638273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of vaginal ointment of honey and clotrimazole for treatment of vulvovaginal candidiasis: A random clinical trial.
    Banaeian S; Sereshti M; Rafieian M; Farahbod F; Kheiri S
    J Mycol Med; 2017 Dec; 27(4):494-500. PubMed ID: 28760590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nanotechnological mucoadhesive and fast-dissolving film for vaginal delivery of clotrimazole: design, characterization, and in vitro antifungal action.
    Cervi VF; Saccol CP; da Rosa Pinheiro T; Santos RCV; Sari MHM; Cruz L
    Drug Deliv Transl Res; 2022 Dec; 12(12):2907-2919. PubMed ID: 35499713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical delivery systems containing clotrimazole for the management of candidiasis: Effect of different excipients and enhanced antifungal activity of nanovesicles.
    Usach I; Martínez-Álvarez P; Peris JE
    Int J Pharm; 2023 Sep; 644():123287. PubMed ID: 37536641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.
    Woodburn KW; Clemens LE; Jaynes J; Joubert LM; Botha A; Nazik H; Stevens DA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.